Hualu Hengsheng: The adipic acid plant of nylon 66 high-end new material project was put into production. Hualu Hengsheng (600426) announced on the evening of December 11th that the adipic acid plant of the company's nylon 66 high-end new material project had been put through the process, produced qualified products and entered the trial production stage. Production facilities such as nylon 66 are currently under construction. After the adipic acid plant is put into production, 200,000 tons/year of adipic acid can be added, which lays a foundation for the company to further expand the new chemical materials sector and is conducive to improving the comprehensive competitiveness of enterprises.Lexin Technology's daily limit of 20cm today was 192 million yuan, and Lexin Technology's daily limit was 20cm today, with a turnover of 2.799 billion yuan and a turnover rate of 12.22%. After-hours data showed that the special seats of Shanghai Stock Connect bought 215 million yuan and sold 226 million yuan, and the special seats of the two institutions sold 192 million yuan.Zhewen Internet: Zhejiang Internet (600986) announced on the evening of December 11th that the company intends to authorize the management of the company to make an independent decision to dispose of the stock of Doushen Education Technology (Beijing) Co., Ltd. (hereinafter referred to as "Doushen Education") held by the company through centralized bidding or block trading. The authorization period is within 36 months from the date of deliberation and approval by the shareholders' meeting. As of the date of announcement, the company holds 61.06 million shares of Doushen Education, accounting for 2.95% of the total share capital of Doushen Education, and will lift the restriction on sales on December 29, 2024.
Modern Pharmaceuticals: Sinopharm Zhijun, the holding subsidiary, obtained the drug registration certificate of Cefotaxime Tablets. Modern Pharmaceuticals announced that Sinopharm Zhijun Pharmaceutical Co., Ltd., the holding subsidiary, recently received the Drug Registration Certificate of Cefotaxime Tablets approved and issued by National Medical Products Administration. Cefopoxime axetil tablets are the third generation cephalosporins taken orally, which are used to treat upper respiratory tract infections and lower respiratory tract infections caused by sensitive bacteria. In 2023, the global sales of preparations will be USD 370 million, and the sales of public hospitals nationwide will be RMB 102 million. The accumulative R&D investment of Sinopharm Zhijun is about RMB 28.45 million. Obtaining the registration certificate will enrich the company's product line, increase market competitiveness and have a positive impact on the company's future development. However, drug sales are easily affected by factors such as policies and market environment, and there are uncertainties.Yao Anna became the brand ambassador of Baique Ling, and Baique Ling officially announced Yao Anna as the brand ambassador on December 11th.The President of Peru called for the restoration of the death penalty for criminals who raped children, and the President of Peru Dina Ersilia Brou Art segala called for the restoration of the death penalty for criminals who raped children on the 10th. Earlier, a 12-year-old girl in the capital Lima was killed after being suspected of sexual assault. (Xinhua News Agency)
SDIC Power and others have invested in the establishment of a new energy development company. The enterprise search APP shows that recently, Ganzi Yalongjiang Energy Development Co., Ltd. was established with Zhang Peng as its legal representative and a registered capital of 500 million yuan. Its business scope includes: solar power generation technical services; Research and development of emerging energy technologies; Technical services for wind power generation; Energy storage technology services, etc. Enterprise equity penetration shows that the company is jointly owned by Yalong River Basin Hydropower Development Co., Ltd. and Ganzi Energy Development Group Co., Ltd., a subsidiary of SDIC Power.Changhong Meiling: It plans to use its own idle funds not exceeding 6.35 billion yuan to invest in wealth management products. Changhong Meiling announced that in order to improve the efficiency of the company's use of funds, increase the company's cash assets income, and maximize the interests of shareholders, the company and its subsidiaries (excluding Zhongke Meiling Cryogenic Technology Co., Ltd. and its subsidiaries) will use their own idle funds not exceeding 6.35 billion yuan (this amount can be used in a rolling way) to invest and purchase products with high safety, good liquidity and a term of less than one year.Shenzhen reports an explosion in a residential building: fire rescue forces have arrived, and Shenzhen Fire Release Report: At 14: 46 on December 11, 2024, Shenzhen Fire Rescue Detachment received an alarm: an alarm occurred in Yuefu Phase II Building, Yuehai Street, Nanshan District, and the command center dispatched 16 fire engines and 80 fire rescue personnel from the first battle force to the scene for disposal, and the full-time command group of Nanshan Brigade was dispatched. At present, fire rescue forces have arrived, and the specific situation needs further verification.
Strategy guide 12-14
Strategy guide
12-14